News

Protective drug dexrazoxane reduces heart damage in paediatric cancer survivors years after treatment ends

Targeting the 4EBP1/HSP90β/Nrf2 axis sensitizes β-catenin-mutant hepatocellular carcinoma to mTOR inhibitors via ferroptosis induction

Growth hormone therapy helps childhood stem cell transplant survivors grow taller, but responses vary widely

New biomarker interaction may help predict breast cancer metastasis and identify patients most likely to benefit from treatment

Newly identified C/EBPγ protein links cancer cell plasticity and DNA repair, promoting therapy resistance in lung adenocarcinoma

Uncovering a new vulnerability in acute myeloid leukaemia

Radiopharmaceutical may benefit patients with metastatic prostate cancer sooner

Tuft cell-like tumours define an emerging cancer subtype with distinct biology and therapeutic potential

Ferroptosis and prostate cancer: translating iron-dependent cell death into precision oncology

Targeting autophagy could help overcome cisplatin resistance in gastric cancer

A ‘double-punch’ approach to tackling brain cancer

New insights into the hidden dialogue between nerves and cancer open pathways for innovative treatments